Allianz Research Institute | Westminster, CA

Research site

(Unclaimed)

Location

14120 Beach Boulevard 101, Westminster, California, United States of America

Site insights

Top conditions

Top treatments

Dupilumab

Verekitug

Astegolimab

EDP-938

UPB-101

Bococizumab

Albuterol Sulfate

JNJ-95597528

BPS-314d-MR-PAH-303

DUPIXENT®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 22 total trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting

Severe Asthma

Drug: Verekitug

Drug: Placebo

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma (READY-BREATHE)

The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (lon...

Enrolling

Asthma

Drug: JNJ-95597528

Drug: Placebo

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Other: Placebo

Drug: Verekitug

Status recently updated

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Enrolling

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Drug: Astegolimab

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting

Asthma

Drug: TEV-56248

Drug: Albuterol sulfate

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma (AIM4:Next Step)

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the air...

Active, not recruiting

Asthma

Drug: dupilumab

Drug: Matching Placebo

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Active, not recruiting

Asthma

Drug: Placebo

Drug: Dupilumab